MENS - Jyong Biotech Ltd. Ordinary Shares

MENS - Jyong Biotech Ltd. Ordinary Shares

https://jyongbio.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention

GlobeNewswire • 1 month, 3 weeks ago • score: 0.27

New Taipei City, Taiwan, July 22, 2025 ( GLOBE NEWSWIRE ) -- Jyong Biotech Ltd. ( Nasdaq: MENS ) ( the "Company", "Jyong Biotech" ) , a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs ( plant-derived ) ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

None

52W High

$61.00

52W Low

$6.01

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

As of 2024-12-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

N/A

Ownership

Source: Overview

Insiders (1–5% typical)

62.21%

Institutions (25–75% balanced)

0.00%

Shares Outstanding

76,028,000

Float

26,947,500

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

As of 2024-12-31 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-0.04

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

8.5955

Previous

8.5859

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025